Med Pharma Congress 2019

Theme: Novelties in Pharmaceutical and Medical Sciences

Med Pharma Congress 2019

About conference:

Conference Series llc LTD invites all the participants from all over the world to attend 19th Annual Medicinal & Pharmaceutical Sciences Congress which is scheduled on March 25-26, 2019 at Hong Kong. Conference includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions and rails with the theme “Novelties in Pharmaceutical and Medical Sciences”. Med Pharma congress provides new information and discussions on current researches and different ideas are exchanged among experts.

Why to Attend???

Med Pharma congress provides you excellent opportunities to disseminate research, share best practice, network with colleagues and refresh clinical knowledge in Pharma and medicinal field. You can also find out how innovators are closing the gap between product development and adoption, conduct demonstrations, distribute information, meet with current and potential Scientists, make a splash with a new research, in Pharmaceutical Science & Medicinal Chemistry. The speciality of the conference is World-renowned speakers, top experts in pharma field, the most recent techniques in current research, tactics, and the newest updates in Pharmaceutical Sciences fields

It’s a Unique Opportunity for Advertisers and Sponsors at this International event:

Target Audience:

Professors, Associate Professors, Assistant Professors
PhD Scholars
Graduates and Post Graduates
Directors, CEO’s of Organizations
Association, Association presidents and professionals
Noble laureates in Health Care and Medicine
Bio instruments Professionals
Bio-informatics Professionals
Software development companies
Research Institutes and members
Supply Chain companies
Manufacturing Companies
CRO and DATA management Companies
Training Institutes
Business Entrepreneur
Government healthcare departments, HTA’s and drug regulators
Digital health companies
Genomics and personalised medicine experts

1. Pharmaceutical Chemistry:

Medicinal chemistry or Pharmaceutical Chemistry mainly deals with the drug design, optimization and development of chemical compounds. This field includes multidisciplinary topic such as synthesis of potential drugs followed by studies investigating their interactions with biological targets to understand the medicinal effects of the drug, its metabolism and side-effects

Conferences: 21st Annual European Pharma Congress May 20-22, 2019 Zurich; Switzerland, 18th International Conference on Pharmaceutics & Novel Drug Delivery Systems May 27-28, 2019 Istanbul, Turkey; USA Medical Conferences; 7th international conference and Exhibition on Pharmacognosy, Phytochemistry and Natural Products June 10-11, 2019 Osaka, Japan; Pharmaceutical Conferences Asia; 7th European Biopharma Congress July 29-30, 2019 Stockholm, Sweden; Medical Conferences Europe; Pharmaceutical Conferences Europe; 5th World Congress on Medicinal Plants and Natural Products Research July 15-16, 2019 Hong Kong; 9th International Conference on Pharmaceutical GMP, GCP & Regulatory Affairs August 02-03, 2019 Chicago, USA; Pharmaceutical Conferences USA; International Medical Conferences; 2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry August 02-03, 2019 Chicago, USA; 24th World Congress on Pharmacology August 19-20, 2019 Vienna, Austria; Pharmaceutical Conferences Middle East; 4th World Congress on Pharmacology and Toxicology September 11-12, 2019 Singapore

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

2. Pharmacology and Toxicology:

Pharmacology is that the scientific study of drug action on biological systems. It is the study of the interactions between a living organism and drugs, defined as the branch of medicine concerned with the uses, effects, and modes of action of drugs

Toxicology is that the study of the adverse effects of chemicals or physical agents on living organisms. The scientific study of adverse effects is that occur in the living organisms due to the chemicals. It has a key role in the development of new drugs, which are evaluated for potential toxic effects in pre-clinical studies, clinical trials and post-marketing studies with the aim of ensuring that their benefits outweigh their risks.

3. Bio Phaemaceuticals:

Biopharmaceutical Science contains the study of the drug discovery and their development, and along with their properties, both physical and chemical. It conjointly deals with the biological effects of the medicine like onset and period of action beside their intensity within the body. Bio pharmaceutics facilitate in calculative the bio availability and therapeutic activity of the medicine within the body

4. Pharmaceutical Formulations

Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.

Preformulation involves the characterization of a drug's physical, chemical, and mechanical properties in order to choose what other ingredients (excipients) should be used in the preparation. In dealing with protein pre-formulation, the important aspect is to understand the solution behavior of a given protein under a variety of stress conditions such as freeze/thaw, temperature, shear stress among others to identify mechanisms of degradation and therefore its mitigation.

5. Pharmacovigilance

Pharmacovigilance is also known as drug safety, and it is the practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse drug reactions.

6. Ethnomedicine

Ethnomedicine is a study or comparison of the traditional medicine based on bioactive compounds in plants and animals and practiced by various ethnic groups, especially those with little access to western medicines, e.g., indigenous peoples. The word ethnomedicine is sometimes used as a synonym for traditional medicine

7. Pharmaceutical Analytical Techniques

Pharmaceutical analytical techniques explain the process or different processes to identify and quantify a substance, the components of a pharmaceutical solution or mixture or the determination of the structures of chemical compounds used in manufacturing of the pharmaceutical product. The components monitored include process impurities, chiral or achiral drugs, residual solvents, degradation products, excipients such as preservatives, extractable and leachable from container and closure or manufacturing process, pesticide in drug product from plant origin, and metabolites.

8. Pharmacoepidemiology:

Pharmacoepidemiology is the study of the utilization and effects of drugs in large numbers of people; it provides an estimate of the probability of beneficial effects of a drug in a population and the probability of adverse effects. It can be called a bridge science spanning both clinical pharmacology and epidemiology. Pharmacoepidemiology concentrates on clinical patient outcomes from therapeutics by using methods of clinical epidemiology and applying them to understanding the determinants of beneficial and adverse drug effects, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions, and the effects of medication non-adherence.

9. Pharmacognosy and Phytochemistry:Pharmacognosy the branch concerned with medicinal drugs obtained from plants or other natural sources. It is also defined as the study of the physical, chemical, biochemical and biological properties of drugs, drug substances which are origin from natural sources.

Phytochemistry is in the study of phytochemicals in plants and other natural sources. Phytochemicals are chemicals derived from plants. In other words the terms are often used to describe the large number of primary and secondary metabolic compounds found in plants. Phytochemicals have properties such as protection against insect attacks and diseases. They also exhibit a number of protective functions for human beings also.

10. Pharmacogenomics:

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.

11. Analytical and Bio analytical Techniques:

Analytical and Bio analytical Techniques in which it includes analytical methods used for the characterization, release, and stability testing for chemical compounds and for new drugs also as well as the biotechnological/biological products and related to sciences and pharma.

12. Hospital & Healthcare management:

Healthcare Management may be a totally different system within the management trade. In which it deals with the various field about leadership, management, administration of hospitals, hospital networks, etc. in Hospital Management it is a facility that the services are provided to the hospitals and patients.

13. Industrial Pharmacy:

Industrial Pharmacy mainly deals with the drug research, design, development and also testing, treatments of new medicines, and more over ensuring safety and quality of drugs. And it includes areas relates to different functions in the pharmaceutical industry and having contact with the areas like engineering and economics.

14. Regulatory Affairs:

Drug Regulatory Affairs refers to all aspects within the pharmaceutical development process and how they are subject to various degrees of regulation. The pharmaceutical law frame, guidelines covering Quality, Safety and Efficacy as well as Health Authorities' attitudes and requirements etc. have a great influence on the drug development process and the success of it. Regulatory affairs professionals deal with these aspects.

15. Intellectual Property Rights (IPR):

Industrial property (IP) rights are extremely important for the pharmaceutical industry. The use of the IP system by SMEs in the pharmaceutical industry depends largely on the business strategy of a company, its size, resources, innovative capacity, competitive context and field of expertise. Research-based, innovation-led companies that seek to develop new drugs improve or adapt existing drugs or develop new pharmaceutical/medical equipment or processes, tend to rely heavily on the patent system to ensure they recover the investments incurred in research and development.

The medical technology industry is an eminent part of the healthcare sector. It includes, most of all, medical devices which simplify the prevention, diagnosis and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines and implants.

Global:

The global market for medical device technologies reached $458.3 billion in 2015. The market should reach $483.5 billion in 2016. The global market for medical devices technologies reached nearly $521.2 billion in 2017 and should reach $674.5 billion by 2022, at a compound annual growth rate (CAGR) of 5.3% for the period of 2017-2022.

Asia Pacific:

Asia-Pacific medical equipment maintenance market is expected to reach USD 9,054.0 million by 2025 from USD 4,897.9 million in 2017, at the highest of 8.1% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Hong Kong:

Notably, drug spending from the special administrative region's Samaritan Fund - established to finance the health expenditure of low-income people - rose by a significant 12% y-o-y to amount to HKD26 9mn (USD34mn). In aggregate, public funding of pharmaceuticals in Hong Kong rose by 7% y-o-y to amount to HKD5.9bn (USD770mn) for the year.

This growth in pharmaceutical spending in Hong Kong falls in line with our expectations, and we will thus maintain our forecast. We project top-line medicine spending in the special administrative region to grow from HKD9.6bn (USD1.2bn) in 2016, to HKD13.4bn (USD1.7bn) by 2021 and HKD18bn (USD2.3bn) by 2026.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	March 25-26, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View